S. Taube
Statistics and Probability · 2005–2012
A researcher in the Science corpus: 9 papers; trusts 16 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 43 citations into it
- Genetics — 29 citations into it
- Economics and Econometrics — 16 citations into it
Whom S. Taube trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Patrick Royston
- Willi Sauerbrei
- Patrick M. M. Bossuyt
- David W. Hosmer Jr.
- Jr. Frank E. Harrell
- Michael R. Chernick
- Lisa M. McShane
Who trusts S. Taube overall
Papers from S. Taube's perspective
Ordered by how strongly the researchers S. Taube trusts endorse each paper. Same corpus, a different order for every researcher.
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (Annals of Internal Medicine)
- Dichotomizing continuous predictors in multiple regression: a bad idea (Statistics in Medicine)
- The challenge of subgroup analyses--reporting without distorting.
- Practical statistics for medical research
- Survival Analysis Part I: Basic concepts and first analyses (British Journal of Cancer)
- The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. (Clinical Chemistry)
- Applied Survival Analysis: Regression Modeling of Time-to-Event Data
- Bootstrap Methods and their Application
- Why Most Discovered True Associations Are Inflated (Epidemiology)
Their papers
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005) — 764 citations
- Reporting recommendations for tumor marker prognostic studies. (2005) — 808 citations
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012) — 879 citations
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). (2010) — 894 citations
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (2010) — 3,652 citations
- American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. (2010) — 1,006 citations
- American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. (2007) — 1,250 citations
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. (2007) — 1,118 citations
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2006) — 5,113 citations